Noah Richardson - Profile and Journalist Details
Find journalists that align with your industry, location and vision. Unlock Noah Richardson's full journalist profile, including location, coverage topics, current employer, biography and preferences. Sign up today and start building journalist relationships that fuel your startup's growth.
Get connected with journalists today
Noah Richardson
Verified
Producer, CPAC - Cable Public Affairs Channel
Ottawa
Beats
Biography
I'm an honours Journalism and Canadian Studies student at Carleton University in Canada's capital. I'm an experienced producer and multi-platform reporter who's passionate about reporting on politics and Indigenous issues. I'm also a foodie and craft beer enthusiast.
thermal/coal
Content
Nanomaterials Revolutionizing Photovoltaic Efficiency: Innovations in Light Absorption and Structural Flexibility
By Noah Richardson Verified| scitechnol.com@ Perspective, J Nanomater Mol Nanotechnol Vol: 13 Issue: 5 Noah Richardson* 1Department of Molecular Science and Engineering, University of Waterloo, Waterloo, Canada *Corresponding Author: Noah Richardson, Department of Molecular Science and Engineering, University of Waterloo, Waterloo, Canada E-mail: richard_noah7549@edu.ca Received date: 23 September, 2024, Manuscript No. JNMN-24-149317; Editor assigned date: 25 September, 2024, PreQC No. JNMN-24-149317 (PQ); Reviewed date: 09 October,...
High‐dose chemotherapy and peripheral blood stem cell transplantation as salvage therapy in primary mediastinal nonseminomatous germ cell tumors: The Indiana University experience
By Noah Richardson Verified, Fadi Taza, Rafat Abonour, Sandra K. Althouse| Wiley Online Library Verified INTRODUCTION Primary extragonadal germ cell tumors comprise only 5% of germ cell tumors and arise most commonly in the mediastinum in adults.1 Primary mediastinal nonseminomatous germ cell tumors (PMNSGCTs), although similar in histology and cytogenetics to testicular germ cell tumors, have less response to cisplatin-based chemotherapy and are classified as poor-risk disease regardless of other factors, such as the size of the tumor, amplitude of serum tumor markers (STMs), and other factors...
By Noah Richardson Verified, Jonathan Bryant, Marko Radic, Jordan B. Luttrell| Biomed Central (BMC)@ AbstractBackgroundSimultaneous advances in gene editing, T cell engineering and biotechnology currently provide an opportunity for rapid progress in medicine. The approval of chimeric antigen receptor (CAR) T cell therapies by the US Food and Drug Administration (FDA) and the European Commission have generated substantial momentum for these first-in-class therapies to be used in patients with B cell malignancies.
Company Info
CPAC - Cable Public Affairs Channel
CPAC (Cable Public Affairs Channel) is Canada's only national, bilingual media network focused on non-partisan coverage of parliamentary proceedings, political events, and public policy debates. Established in 1992 by a group of cable companies, CPAC operates as a not-for-profit, commercial-free organization dedicated to providing Canadians with direct access to federal political institutions. Headquartered in Ottawa, CPAC emphasizes transparency in governance and maintains editorial independence. The network offers live broadcasts of House of Commons proceedings, including debates and committee hearings. It also features public affairs programming that covers various issues such as healthcare and climate change. CPAC provides on-demand video streaming through its digital platforms and maintains an extensive archive of past parliamentary sessions for public reference. With a commitment to neutrality and balance, over 90% of its programming is produced in Canada and delivered in both English and French.
'+1 613-567-2741
Founded: 1992